BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company IGALMI, a sublingual film for the...
42 insider purchases on record · latest filing 2021-02-16.
Insiders have also filed 103 sale transactions at BTAI.